Literature DB >> 10969671

Induction of angiogenesis after TMR: a comparison of holmium: YAG, CO2, and excimer lasers.

G C Hughes1, A P Kypson, B H Annex, B Yin, J D St Louis, S S Biswas, R E Coleman, T R DeGrado, C L Donovan, K P Landolfo, J E Lowe.   

Abstract

BACKGROUND: Transmyocardial laser revascularization (TMR) is an emerging treatment for end-stage coronary artery disease. A variety of lasers are currently available to perform the procedure, although their relative efficacy is unknown. The purpose of this study was to compare changes in myocardial blood flow and function 6 months after TMR with holmium:yttrium-aluminum-garnet (holmium:YAG), carbon dioxide (CO2), and xenon chloride excimer lasers in a model of chronic ischemia.
METHODS: Miniswine underwent subtotal (90%) left circumflex coronary stenosis. Baseline positron emission tomography and dobutamine stress echocardiography were performed to document hibernating myocardium in the left circumflex coronary artery distribution. Animals were then randomized to sham redo-thoracotomy (n = 5) or TMR using a holmium:YAG (n = 5), CO2 (n = 5) or excimer (n = 5) laser. Six months postoperatively, the positron emission tomography and dobutamine stress echocardiography studies were repeated and the animals sacrificed.
RESULTS: In animals undergoing TMR with holmium: YAG and CO2 lasers, a significant improvement in myocardial blood flow to the lased left circumflex regions was seen. No significant change in myocardial blood flow was seen in sham- or excimer-lased animals. There was a significant improvement in regional stress function of the lased segments 6 months postoperatively in animals undergoing holmium:YAG and CO2 laser TMR that was consistent with a reduction in ischemia. There was no change in wall motion in sham- or excimer-lased animals. Significantly greater neovascularization was observed in the holmium:YAG and CO2 lased regions than with either the sham procedure or excimer TMR.
CONCLUSIONS: Transmyocardial laser revascularization with either holmium:YAG or CO2 laser improves myocardial blood flow and contractile reserve in lased regions 6 months postoperatively. These changes were not seen following excimer TMR or sham thoracotomy, suggesting that differences in laser energy or wavelength or both may be important in the induction of angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10969671     DOI: 10.1016/s0003-4975(00)01569-1

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

1.  Transmyocardial revascularization ameliorates ischemia by attenuating paradoxical catecholamine-induced vasoconstriction.

Authors:  D Elizabeth Le; Eric R Powers; Jian-Ping Bin; Howard Leong-Poi; N Craig Goodman; Sanjiv Kaul
Journal:  J Nucl Cardiol       Date:  2007-04       Impact factor: 5.952

Review 2.  Transmyocardial laser revascularization.

Authors:  Keith A Horvath
Journal:  J Card Surg       Date:  2008 May-Jun       Impact factor: 1.620

3.  Regenerative concepts in cardiovascular research: novel hybrid therapy for remodeling ischemic cardiomyopathy.

Authors:  Prashant Rao; Rinku Skaria; Zain Khalpey
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

4.  Transmyocardial revascularization (TMR): current status and future directions.

Authors:  Keith B Allen; Amy Mahoney; Sanjeev Aggarwal; John Russell Davis; Eric Thompson; Alex F Pak; Jessica Heimes; A Michael Borkon
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2018-10-08

5.  Mid term results after bone marrow laser revascularization for treating refractory angina.

Authors:  Guillermo Reyes; Keith B Allen; Pablo Alvarez; Adrian Alegre; Beatriz Aguado; MariaJose Olivera; Paloma Caballero; JoseLuis Rodríguez; Juan Duarte
Journal:  BMC Cardiovasc Disord       Date:  2010-09-17       Impact factor: 2.298

Review 6.  Transmyocardial revascularization devices: technology update.

Authors:  Bogdan A Kindzelski; Yifu Zhou; Keith A Horvath
Journal:  Med Devices (Auckl)       Date:  2014-12-18

Review 7.  Clinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging.

Authors:  Jessika Iwanski; Shannon M Knapp; Ryan Avery; Isabel Oliva; Raymond K Wong; Raymond B Runyan; Zain Khalpey
Journal:  J Cardiothorac Surg       Date:  2017-05-19       Impact factor: 1.637

8.  Laser-supported CD133+ cell therapy in patients with ischemic cardiomyopathy: initial results from a prospective phase I multicenter trial.

Authors:  Alexander Assmann; Michael Heke; Patric Kröpil; Lena Ptok; Dieter Hafner; Christian Ohmann; Andreas Martens; Antje Karluβ; Maximilian Y Emmert; Ingo Kutschka; Hans-Hinrich Sievers; Hans-Michael Klein
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

Review 9.  Remodeling an infarcted heart: novel hybrid treatment with transmyocardial revascularization and stem cell therapy.

Authors:  Jessika Iwanski; Raymond K Wong; Douglas F Larson; Alice S Ferng; Raymond B Runyan; Steven Goldstein; Zain Khalpey
Journal:  Springerplus       Date:  2016-06-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.